When Do We Say What On Pay?
It’s that time again. For companies that are required to hold advisory shareholder “say-on-pay” votes on their executive compensation,...
Expert views and insights from our team on the latest developments in the industry.
Posts: | 370 | |
Reposts: | 0 |
It’s that time again. For companies that are required to hold advisory shareholder “say-on-pay” votes on their executive compensation,...
In a rare move on February 27, 2023, the Federal Trade Commission (FTC) issued its first statement akin to a closing statement since...
Acquisitions of public companies in pharma, biotech, and other life sciences industries are increasingly using deal structures designed...
For over a decade, industry watchdogs, patient groups and various lawmakers have been calling for drug pricing reform—initially with...
We're pleased to announce Freshfields' 2022 De-SPAC Debrief: A comprehensive review of all 102 de-SPAC transactions that closed in 2022....
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net